How Could a New Longevity Medicine Create $200B Per Year in Revenue? Dr. Greg Bailey and I asked top VC Alex Colville from age1
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
Market sizing the first longevity-approved drug
Alex summarizes Age1's analysis estimating the first drug labeled for longevity could reach $150–200B annual revenue and reshape pharma market value.
Transcript
Play full episode
